| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9643539 | Journal of the American Academy of Child & Adolescent Psychiatry | 2005 | 5 Pages |
Abstract
In this open trial, fluvoxamine appeared to be well tolerated and was associated with a promising reduction in the depression and anxiety symptoms of pediatric patients with cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
DORON M.D., MALY R.N., EYAL M.D., ORIT M.A., ILANA M.D., ANAT M.A., ABRAHAM M.D., ALAN M.D., ISAAC M.D.,